These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 2547137

  • 1. Long-term and withdrawal effects of two different oestrogen-progestogen combinations on lipid and lipoprotein profiles in post-menopausal women.
    Jensen J, Riis BJ, Strøm V, Christiansen C.
    Maturitas; 1989 Jun; 11(2):117-28. PubMed ID: 2547137
    [Abstract] [Full Text] [Related]

  • 2. Cyproterone acetate, an alternative progestogen in postmenopausal hormone replacement therapy? Effects on serum lipids and lipoproteins.
    Jensen J, Riis BJ, Christiansen C.
    Br J Obstet Gynaecol; 1987 Feb; 94(2):136-41. PubMed ID: 3030392
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy: lipid responses to continuous combined oestrogen and progestogen versus oestrogen monotherapy.
    Metka M, Hanes V, Heytmanek G.
    Maturitas; 1992 Aug; 15(1):53-9. PubMed ID: 1326708
    [Abstract] [Full Text] [Related]

  • 4. Effects of tibolone or continuous combined oestradiol and norethisterone acetate on lipids, high-density lipoprotein subfractions and apolipoproteins in postmenopausal women in a two-year, randomized, double-blind, placebo-controlled trial.
    Kotecha PT, Godsland IF, Crook D, Stevenson JC.
    Clin Endocrinol (Oxf); 2020 Apr; 92(4):303-311. PubMed ID: 31925799
    [Abstract] [Full Text] [Related]

  • 5. Dose-response effects on serum lipids and lipoproteins following combined oestrogen-progestogen therapy in post-menopausal women.
    Jensen J, Christiansen C.
    Maturitas; 1987 Nov; 9(3):259-66. PubMed ID: 3323852
    [Abstract] [Full Text] [Related]

  • 6. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 7. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O, Lim P, Caubel P.
    Clin Ther; 2000 May 15; 22(5):622-36. PubMed ID: 10868559
    [Abstract] [Full Text] [Related]

  • 8. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B, Guzic-Salobir B, Sebestjen M, Keber I.
    Menopause; 2006 May 15; 13(4):643-50. PubMed ID: 16837886
    [Abstract] [Full Text] [Related]

  • 9. Changes in normal lipid profile of menopausal women with combined hormone replacement therapy. Comparative clinical trial of two hormonal combinations (conjugated estrogens/medroxyprogesterone acetate versus estradiol valerate/cyproterone acetate).
    Alwers R, Urdinola J, Onatra W, Sánchez F, Posso H.
    Maturitas; 1999 May 31; 32(1):41-50. PubMed ID: 10423715
    [Abstract] [Full Text] [Related]

  • 10. Continuous oestrogen-progestogen treatment and serum lipoproteins in postmenopausal women.
    Jensen J, Riis BJ, Strøm V, Christiansen C.
    Br J Obstet Gynaecol; 1987 Feb 31; 94(2):130-5. PubMed ID: 3828253
    [Abstract] [Full Text] [Related]

  • 11. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R, Heinemann L, Heise T, Bender R, Weyer C, Hirschberger S, Berger M.
    Menopause; 1999 Feb 31; 6(1):36-42. PubMed ID: 10100178
    [Abstract] [Full Text] [Related]

  • 12. Lipoproteins and low-dose estradiol replacement therapy in post-menopausal Type 2 diabetic patients: the effect of addition of norethisterone acetate.
    Owens D, Collins PB, Johnson A, Tomkin GH.
    Diabet Med; 2000 Apr 31; 17(4):308-15. PubMed ID: 10821298
    [Abstract] [Full Text] [Related]

  • 13. Responses of HDL subclasses, Lp(A-I) and Lp(A-I:A-II) levels and lipolytic enzyme activities to continuous oral estrogen-progestin and transdermal estrogen with cyclic progestin regimens in postmenopausal women.
    Tilly-Kiesi M, Kahri J, Pyörälä T, Puolakka J, Luotola H, Lappi M, Lahdenperä S, Taskinen MR.
    Atherosclerosis; 1997 Mar 21; 129(2):249-59. PubMed ID: 9105568
    [Abstract] [Full Text] [Related]

  • 14. A randomised comparison of the effects of oral versus transdermal 17beta-oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels.
    Spencer C, Crook D, Ross D, Cooper A, Whitehead M, Stevenson J.
    Br J Obstet Gynaecol; 1999 Sep 21; 106(9):948-53. PubMed ID: 10492107
    [Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
    Saure A, Hirvonen E, Milsom I, Christensen A, Damber MG.
    Maturitas; 1996 May 21; 24(1-2):111-8. PubMed ID: 8794442
    [Abstract] [Full Text] [Related]

  • 16. Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17beta-estradiol and norethisterone acetate.
    Samsioe G, Li C, Borgfeldt C, Wilawan K, Aberg A, Larsen S.
    Menopause; 2002 May 21; 9(5):335-42. PubMed ID: 12218722
    [Abstract] [Full Text] [Related]

  • 17. Do combinations of 1 mg estradiol and low doses of NETA effectively control menopausal symptoms?
    Baerug U, Winge T, Nordland G, Faber-Swensson E, Heldaas K, Norling B, Larsen S, Arce JC.
    Climacteric; 1998 Sep 21; 1(3):219-28. PubMed ID: 11907946
    [Abstract] [Full Text] [Related]

  • 18. Benefits and risks of different hormonal replacement therapies in post-menopausal women.
    Volpe A, Facchinetti F, Grasso A, Petraglia F, Campanini D, Genazzani AR.
    Maturitas; 1986 Dec 21; 8(4):327-34. PubMed ID: 3033444
    [Abstract] [Full Text] [Related]

  • 19. Time-related effects of a progestogen on the isoforms of serum gonadotrophins in 17 beta-oestradiol treated post-menopausal women.
    Wide L, Naessén T, Eriksson K, Rune C.
    Clin Endocrinol (Oxf); 1996 Jun 21; 44(6):651-8. PubMed ID: 8759177
    [Abstract] [Full Text] [Related]

  • 20. Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen-progestogen regimens in post-menopausal women.
    Hirvonen E, Lipasti A, Mälkönen M, Kärkkäinen J, Nuntila J, Timonen H, Manninen V.
    Maturitas; 1987 Apr 21; 9(1):69-79. PubMed ID: 2955205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.